Natco Pharma Share Price Target, Future Prediction, Prognosis, Forecast 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2031, 2035, 2040, 2050
Are you curious about the potential of Natco Pharma stock in the future? Then don’t worry In this blog post, we’ll explore future predictions and discuss factors that might influence the Natco Pharma share price in the coming years. We’ll provide Natco Pharma share price targets for 2024, 2025, 2026, and even far out to 2030, 2035, 2040, and 2050.
We can do the research and take advice from the stock experts to make this blog about the company’s performance and growth but, Keep in mind that these are just predictions, and the actual price could be higher or lower. But they can give you a general idea of what experts think about the stock’s long-term outlook.
So If you want to know how this stock will perform in the upcoming years, read this blog post completely and properly.
What Is Natco Pharma Ltd.?
Natco Pharma is an Indian multinational pharmaceutical firm headquartered in Hyderabad. The company develops final dosage formulations, active medicinal components, and agricultural chemical products.
It is a prominent manufacturer of branded oncology, cardiology, diabetology, and other pharmaceutical specialty products. The company specializes in developing complex medicines at a reasonable price. NATCO is a science-driven corporation that focuses on compounds with low competition in the United States.
NATCO Pharma was founded in the year 1981 by V C Nannapaneni. In 1983 operations commenced at a manufacturing facility at Nagarjunasagar, Telangana.
NATCO introduced the first generic version of Revlimid in the US market.
For the fiscal year 2024, NATCO achieved its greatest-ever revenue, earnings before interest, taxes, depreciation, and amortization, and profit after tax.
Natco Pharma Share Price Growth Chart
Natco Pharma Share Price Target 2024
| 2024 | Share Price Target |
|---|---|
| January | x |
| February | x |
| March | x |
| April | x |
| May | x |
| June | x |
| July | x |
| August | x |
| September | ₹1,554.35 |
| October | ₹1,564.67 |
| November | ₹1,573.78 |
| December | ₹1,588.09 |
By the end of 2024, the company’s stock price might reach ₹1,588.09 per share based on performance and current market data.
ALSO READ:- Infibeam Share Price Target
Natco Pharma Share Price Target 2025
| 2025 | Share Price Target |
|---|---|
| January | ₹1,575.89 |
| February | ₹1,578.09 |
| March | ₹1,586.90 |
| April | ₹1,583.67 |
| May | ₹1,589.09 |
| June | ₹1,594.46 |
| July | ₹1,596.19 |
| August | ₹1,599.34 |
| ber | ₹1,623.00 |
| October | ₹1,637.57 |
| November | ₹1,649.24 |
| December | ₹1,661.18 |
According to current market analysis and performance, the company’s stock price can reach ₹1,661.18 per share by the end of 2025.
Natco Pharma Share Price Target 2026
| 2026 | Share Price Target |
|---|---|
| January | ₹1,674.67 |
| February | ₹1,679.78 |
| March | ₹1,687.09 |
| April | ₹1,692.98 |
| May | ₹1,696.04 |
| June | ₹1,623.98 |
| July | ₹1,666.26 |
| August | ₹1,705.8 |
| September | ₹1,714.80 |
| October | ₹1,720.35 |
| November | ₹1,731.18 |
| December | ₹1,755.46 |
By the end of 2026, the company’s stock price might reach ₹1,755.46 per share based on performance and current market data.
ALSO READ:- Saraswati Saree Share Price Target
Natco Pharma Share Price Target 2027
| 2027 | Share Price Target |
|---|---|
| January | ₹1,764.89 |
| February | ₹1,777.09 |
| March | ₹1,789.80 |
| April | ₹1,793.79 |
| May | ₹1,799.56 |
| June | ₹1,812.09 |
| July | ₹1,809.68 |
| August | ₹1,821.09 |
| September | ₹1,826.78 |
| October | ₹1,829.16 |
| November | ₹1,835.47 |
| December | ₹1,846.33 |
By the end of 2027, the company’s stock price might reach ₹1,846.33 per share based on performance and current market data.
Natco Pharma Share Price Target 2028
| 2028 | Share Price Target |
|---|---|
| January | ₹1,856.78 |
| February | ₹1,888.09 |
| March | ₹1,893.67 |
| April | ₹1,891.45 |
| May | ₹1,899.67 |
| June | ₹1,904.36 |
| July | ₹1,911.18 |
| August | ₹1,917.94 |
| September | ₹1,924.37 |
| October | ₹1,938.69 |
| November | ₹1,941.09 |
| December | ₹1,955.99 |
By the end of 2028, the company’s stock price might reach ₹1,955.99 per share based on performance and current market data.
ALSO READ:- JSW Infrastructure Share Price Target
Natco Pharma Share Price Target 2030
| 2030 | Share Price Target |
|---|---|
| January | ₹2,237.89 |
| February | ₹2,289.09 |
| March | ₹2,311.51 |
| April | ₹2,327.18 |
| May | ₹2,347.67 |
| June | ₹2,355.09 |
| July | ₹2,378.89 |
| August | ₹2,379.67 |
| September | ₹2,411.45 |
| October | ₹2,423.23 |
| November | ₹2,444.40 |
| December | ₹2,487.89 |
According to current market analysis and performance, the company’s stock price can reach ₹2,487.89 per share by the end of 2030.
ALSO READ:- Edelweiss Share Price Target
Natco Pharma Share Price Target 2031
| 2031 | Share Price Target |
|---|---|
| March | ₹2,537.89 |
| June | ₹2,569.09 |
| September | ₹2,653.45 |
| December | ₹2,777.12 |
By the end of 2031, the company’s stock price might reach ₹2,777.12 per share based on performance and current market data.
Natco Pharma Share Price Target 2035
| 2035 | Share Price Target |
|---|---|
| March | ₹3,169.89 |
| June | ₹3,252.09 |
| September | ₹3,340.45 |
| December | ₹3,499.37 |
By the end of 2035, the company’s stock price might reach ₹3,499.37 per share based on performance and current market data.
ALSO READ:- Indegene Share Price Target
Conclusion
I hope this blog post will help you gain some basic knowledge about Natco Pharma Price Target, but remember these forecasts are just a roadmap, not a guaranteed destination. The stock market can be unpredictable, so it’s important to research and consider your investment goals before making any decisions.
But with the knowledge you’ve gained about Natco Pharma’s share Price potential, you’re well on your way to making informed choices about your investment journey.
I hope this blog post is helpful for you, If any doubt regarding this share price Target then please comment below, and I will reply to you.
Disclaimer:- The information provided in this blog post is for informational purposes only and should not be considered as financial advice We are not SEBI registered advisors. Past performance is not a guarantee of future results. Always do your research and consult with a financial professional before making any investment decisions.
Join WhatsApp Channel
Join Telegram Channel